Salvage treatment of NSCLC recurrence after first‐line chemotherapy failure: Iodine‐125 seed brachytherapy or microwave ablation?

BACKGROUND: Salvage treatments for recurrent NSCLC after first‐line chemotherapy remain challenging. This study was conducted to evaluate the clinical value of microwave ablation (MWA) and iodine‐125 brachytherapy, including overall survival (OS), disease free survival (DFS), local control, hospital...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Bin, Wang, Yongzheng, Tian, Shilin, Hertzanu, Yancu, Zhao, Xiaogang, Li, Yuliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049489/
https://www.ncbi.nlm.nih.gov/pubmed/31995853
http://dx.doi.org/10.1111/1759-7714.13320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049489/
https://www.ncbi.nlm.nih.gov/pubmed/31995853
http://dx.doi.org/10.1111/1759-7714.13320

Ejemplares similares